Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.
Bourgier, Celine
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur. [electronic resource] - International journal of radiation oncology, biology, physics 06 2019 - 365-373 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1879-355X
10.1016/j.ijrobp.2019.02.024 doi
Confidence Intervals
Dermatologic Agents--adverse effects
Fibrosis
Head and Neck Neoplasms--radiotherapy
Humans
Pravastatin--adverse effects
Prospective Studies
Quality of Life
Radiation Injuries--drug therapy
Skin--pathology
Squamous Cell Carcinoma of Head and Neck--radiotherapy
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur. [electronic resource] - International journal of radiation oncology, biology, physics 06 2019 - 365-373 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1879-355X
10.1016/j.ijrobp.2019.02.024 doi
Confidence Intervals
Dermatologic Agents--adverse effects
Fibrosis
Head and Neck Neoplasms--radiotherapy
Humans
Pravastatin--adverse effects
Prospective Studies
Quality of Life
Radiation Injuries--drug therapy
Skin--pathology
Squamous Cell Carcinoma of Head and Neck--radiotherapy